0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Proteomics Market by Component (Reagents, Instruments, Services), by Application (Drug Discovery, Disease Diagnosis, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
Published Date: December 2022
|
Report Code: ALLI-Auto-1A97
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Proteomics Market by Component Instruments Reagents and Services and Application Drug Discovery Disease Diagnosis and Others Global Opportunity Analysis and Industry Forecast 2019 2027
BUY CHAPTERS

Proteomics Market by Component (Reagents, Instruments, Services), by Application (Drug Discovery, Disease Diagnosis, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Code: ALLI-Auto-1A97
Report
December 2022
Pages:253
Allied Market Research
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Proteomics Market Report 2031

The global Proteomics Market Size was valued at USD 23,654.34 million in 2021 and is projected to reach USD 98,051.83 million by 2031, growing at a CAGR of 15.2% from 2022 to 2031. The market for proteomics will expand as the increasing focus is placed on the use of products in the development of pharmaceuticals, the identification of biomarkers, and clinical diagnostics for the diagnosis and treatment of diseases.

The rise of the proteomics market is further aided by the protein research being done to treat COVID-19 patients. Additionally, the necessity for personalized treatments and increased R&D spending will foster the expansion of the proteomics market.

Proteomics Market

Proteomics Market Trends

The practice of treating each patient as an individual has replaced the once-universal science of diagnostic and treatment approaches in medicine. Only genetic analysis is now feasible. However, epigenetic, transcriptional, proteomic, posttranslational, metabolic, and environmental factors can affect a patient's response to the illness and treatment. As more analytical and diagnostic techniques are incorporated into clinical practice, the tailored medicine program develops into precision medicine, offering a thorough grasp of the patient's situation. Proteomics can aid precision medicine due to the high precision and sensitivity of mass spectrometric analysis of proteomes. The proteomics market is anticipated to increase as a result of this factor.

A biomarker is an observable sign of a healthy or unhealthy biological situation in the body. In clinical settings, cancer biomarkers are used to track the development of the disease and how well it responds to therapy. 2D-PAGE is used in the finding of biomarkers. The protein profiles of healthy and diseased cells, including tumor tissues and body fluids, can also be contrasted. Cancer biomarkers are divided into three groups based on their intended uses: diagnostic, prognostic, and predictive. Predictive biomarkers can be used to forecast treatment outcomes. This will therefore fuel the market for proteomics to rise.

Chemical, functional, and clinical proteomics-based techniques are used in the multi-stage, complex process of drug development. Proteomics is now being used for patient therapy and care in addition to medication development. 2-DE cannot be used in the creation of new drugs because it cannot separate the membrane proteins that characterize around 50% of important therapeutic targets. Furthermore, 2-DE cannot detect proteins with low quantities. For drug discovery proteomics, it is essential to comprehend how proteins function and interact with other molecules. These methods ought to allow for the detection of low-abundance proteins and their activity. As a result, phage proteins have been recognized and distinguished utilizing a range of methods, such as protein chips and MS. The market for proteomics is anticipated to grow more rapidly as a result.

Additionally, increased healthcare services, significant government investments in healthcare infrastructure, and proteomics-related R&D operations have become vital tools for small and large businesses globally due to the surge in demand for customized medications for particular ailments. This is expected to aid in the market's expansion. The Proteomics Market Size is being driven by the demand for proteomics in both developed and developing countries, such as China, Brazil, and India.

Proteomics Market Share Analysis

The segment with the largest revenue in 2021 was reagents, and it is anticipated that throughout the forecast period, it would expand at a CAGR of 15.5%. The reagent market has the greatest proteomics market share in 2021 and is predicted to keep its dominance during the forecast period because reagents are widely utilized in academic research institutions and research labs to examine a variety of biological samples. The market is expanding as a result of the rising demand for reagents.

Proteomics Market By Component

The market for worldwide proteomics applications was driven by the drug discovery sector in 2021, which accounted for roughly 15.8% of the market. The drug discovery industry is expected to continue to rule the world over the forecasted time period, just as it did in 2021. This is because breakthroughs in proteomics have enabled researchers to develop medications that are specifically tailored for different people in order to achieve greater effectiveness and fewer side effects.

Proteomics Market By Application

North America dominated the proteomics market in 2021, and it is predicted that it would do so again throughout the forecast period. The existence of multiple key companies, a highly established healthcare infrastructure, and an increase in the use of tailored drugs are predicted to fuel market expansion.

Asia-Pacific offers lucrative opportunities for key players operating in the proteomics market due to an increase in the outsourcing of proteomics-based projects, public and private funding for research and development for proteomics studies, favorable government regulations, rising prevalence of target diseases with an aging population, and rising proteomics adoption, which results in registering the fastest growth rate during the forecast period.

Key benefits for stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the proteomics market analysis from 2021 to 2031 to identify the prevailing proteomics market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the proteomics market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global proteomics market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Components

  • Instruments
    • Microarray
    • Spectrometry
      • Mass Spectrometry
      • NMR Spectrometry
    • X-ray Crystallography
    • Chromatography
      • HPLC Systems
      • Ion Chromatography
      • Affinity Chromatography
      • Supercritical Fluid Chromatography
    • Electrophoresis
    • Surface Plasmon Resonance
    • Protein Fractionation Reagents
  • Reagents
    • Microarray
    • Spectroscopy
    • X-ray Crystallography
    • Chromatography
    • Electrophoresis
    • Immunoassay
    • Protein Fractionation Reagents
  • Services

By Application

  • Drug Discovery
  • Disease Diagnosis
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Australia
    • Japan
    • India
    • China
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

By Key Players

Thermo Fisher Scientific Inc., Merck KGaA, Waters Corporation, Bio-Rad Laboratories Inc, Agilent Technologies Inc., Li-Cor Inc, Bruker Corporation, Perkin Elmer Inc, Danaher Corporation, Horiba Ltd.

Scope of the Proteomics Market Report

Report Metric Details
Report Name Proteomics Market
The market size in 2021 USD 23,654.34 Million
The revenue forecast in 2031 USD 98,051.83 Million
Growth Rate Compound Annual Growth Rate (CAGR) of 15.2% from 2022 to 2031
Market size available for years 2022-2031
Forecast units Value (USD)
Segments covered Service, Industry, Traveler, Regions
Report coverage Revenue & volume forecast, company share, competitive landscape, growth factors, and trends
Geographic regions covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Frequently Asked Questions About This Report

1. What will be the global proteomics market size from 2021 to 2030?

Ans. The global Proteomics Market Size was valued at $23,654.34 million in 2021, and is projected to reach $98,051.83 million by 2031, growing at a CAGR of 15.2% from 2022 to 2031. 

2. What are the upcoming trends in proteomics Industry?

Ans. Most of the growth during this period was derived from the Asia-Pacific owing to the rise in prevalence of cancer and chronic diseases and the increase in interest of researchers to utilize proteomics in disease diagnosis & treatment, improving health awareness, rising disposable incomes, as well as the well-established presence of domestic companies in the region. 

3. What is the growth rate of the global proteomics market during the forecast period?

Ans. The global express delivery market is estimated to grow with a Compound Annual Growth Rate (CAGR) of 15.2% during the forecast period.

4. Which is the most influencing segment growing in the proteomics market report?

Ans. By Application, Drug Discovery segment holds a dominant position in 2021 and would continue to maintain the lead over the forecast period.

5. Which region is and will provide more business opportunities for proteomics in the future?

Ans. North America segment holds a dominant position in 2021 and would continue to maintain the lead over the forecast period.

6. Who are the top companies hold the market share in proteomics?

Ans. The key players profiled in this report include Thermo Fisher Scientific Inc., Merck KGaA, Waters Corporation, Bio-Rad Laboratories Inc, Agilent Technologies Inc., Li-Cor Inc, Bruker Corporation, Perkin Elmer Inc, Danaher Corporation, Horiba Ltd.

CHAPTER 1:INTRODUCTION

1.1.Report description

1.2.Key market segments

1.3.Key benefits to the stakeholders

1.4.Research Methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study

2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Market dynamics

3.4.1.Drivers

3.4.2.Restraints

3.4.3.Opportunities

3.5.COVID-19 Impact Analysis on the market

CHAPTER 4: PROTEOMICS MARKET, BY COMPONENT

4.1 Overview

4.1.1 Market size and forecast

4.2. Reagents

4.2.1 Key market trends, growth factors and opportunities

4.2.2 Market size and forecast, by region

4.2.3 Market share analysis by country

4.2.4 Reagents Proteomics Market by Reagents Type

4.3. Instruments

4.3.1 Key market trends, growth factors and opportunities

4.3.2 Market size and forecast, by region

4.3.3 Market share analysis by country

4.3.4 Instruments Proteomics Market by Instruments Type

4.3.4.1 Spectrometry Proteomics Market by Type

4.3.4.2 Chromatography Proteomics Market by Type

4.4. Services

4.4.1 Key market trends, growth factors and opportunities

4.4.2 Market size and forecast, by region

4.4.3 Market share analysis by country

CHAPTER 5: PROTEOMICS MARKET, BY APPLICATION

5.1 Overview

5.1.1 Market size and forecast

5.2. Drug Discovery

5.2.1 Key market trends, growth factors and opportunities

5.2.2 Market size and forecast, by region

5.2.3 Market share analysis by country

5.3. Disease Diagnosis

5.3.1 Key market trends, growth factors and opportunities

5.3.2 Market size and forecast, by region

5.3.3 Market share analysis by country

5.4. Others

5.4.1 Key market trends, growth factors and opportunities

5.4.2 Market size and forecast, by region

5.4.3 Market share analysis by country

CHAPTER 6: PROTEOMICS MARKET, BY REGION

6.1 Overview

6.1.1 Market size and forecast

6.2 North America

6.2.1 Key trends and opportunities

6.2.2 North America Market size and forecast, by Component

6.2.3 North America Market size and forecast, by Application

6.2.4 North America Market size and forecast, by country

6.2.4.1 U.S.

6.2.4.1.1 Key market trends, growth factors and opportunities

6.2.4.1.2 Market size and forecast, by Component

6.2.4.1.3 Market size and forecast, by Application

6.2.4.2 Canada

6.2.4.2.1 Key market trends, growth factors and opportunities

6.2.4.2.2 Market size and forecast, by Component

6.2.4.2.3 Market size and forecast, by Application

6.2.4.3 Mexico

6.2.4.3.1 Key market trends, growth factors and opportunities

6.2.4.3.2 Market size and forecast, by Component

6.2.4.3.3 Market size and forecast, by Application

6.3 Europe

6.3.1 Key trends and opportunities

6.3.2 Europe Market size and forecast, by Component

6.3.3 Europe Market size and forecast, by Application

6.3.4 Europe Market size and forecast, by country

6.3.4.1 Germany

6.3.4.1.1 Key market trends, growth factors and opportunities

6.3.4.1.2 Market size and forecast, by Component

6.3.4.1.3 Market size and forecast, by Application

6.3.4.2 France

6.3.4.2.1 Key market trends, growth factors and opportunities

6.3.4.2.2 Market size and forecast, by Component

6.3.4.2.3 Market size and forecast, by Application

6.3.4.3 UK

6.3.4.3.1 Key market trends, growth factors and opportunities

6.3.4.3.2 Market size and forecast, by Component

6.3.4.3.3 Market size and forecast, by Application

6.3.4.4 Italy

6.3.4.4.1 Key market trends, growth factors and opportunities

6.3.4.4.2 Market size and forecast, by Component

6.3.4.4.3 Market size and forecast, by Application

6.3.4.5 Spain

6.3.4.5.1 Key market trends, growth factors and opportunities

6.3.4.5.2 Market size and forecast, by Component

6.3.4.5.3 Market size and forecast, by Application

6.3.4.6 Rest of Europe

6.3.4.6.1 Key market trends, growth factors and opportunities

6.3.4.6.2 Market size and forecast, by Component

6.3.4.6.3 Market size and forecast, by Application

6.4 Asia-Pacific

6.4.1 Key trends and opportunities

6.4.2 Asia-Pacific Market size and forecast, by Component

6.4.3 Asia-Pacific Market size and forecast, by Application

6.4.4 Asia-Pacific Market size and forecast, by country

6.4.4.1 Japan

6.4.4.1.1 Key market trends, growth factors and opportunities

6.4.4.1.2 Market size and forecast, by Component

6.4.4.1.3 Market size and forecast, by Application

6.4.4.2 China

6.4.4.2.1 Key market trends, growth factors and opportunities

6.4.4.2.2 Market size and forecast, by Component

6.4.4.2.3 Market size and forecast, by Application

6.4.4.3 Australia

6.4.4.3.1 Key market trends, growth factors and opportunities

6.4.4.3.2 Market size and forecast, by Component

6.4.4.3.3 Market size and forecast, by Application

6.4.4.4 India

6.4.4.4.1 Key market trends, growth factors and opportunities

6.4.4.4.2 Market size and forecast, by Component

6.4.4.4.3 Market size and forecast, by Application

6.4.4.5 South Korea

6.4.4.5.1 Key market trends, growth factors and opportunities

6.4.4.5.2 Market size and forecast, by Component

6.4.4.5.3 Market size and forecast, by Application

6.4.4.6 Rest of Asia-Pacific

6.4.4.6.1 Key market trends, growth factors and opportunities

6.4.4.6.2 Market size and forecast, by Component

6.4.4.6.3 Market size and forecast, by Application

6.5 LAMEA

6.5.1 Key trends and opportunities

6.5.2 LAMEA Market size and forecast, by Component

6.5.3 LAMEA Market size and forecast, by Application

6.5.4 LAMEA Market size and forecast, by country

6.5.4.1 Brazil

6.5.4.1.1 Key market trends, growth factors and opportunities

6.5.4.1.2 Market size and forecast, by Component

6.5.4.1.3 Market size and forecast, by Application

6.5.4.2 Saudi Arabia

6.5.4.2.1 Key market trends, growth factors and opportunities

6.5.4.2.2 Market size and forecast, by Component

6.5.4.2.3 Market size and forecast, by Application

6.5.4.3 South Africa

6.5.4.3.1 Key market trends, growth factors and opportunities

6.5.4.3.2 Market size and forecast, by Component

6.5.4.3.3 Market size and forecast, by Application

6.5.4.4 Rest of LAMEA

6.5.4.4.1 Key market trends, growth factors and opportunities

6.5.4.4.2 Market size and forecast, by Component

6.5.4.4.3 Market size and forecast, by Application

CHAPTER 7: COMPANY LANDSCAPE

7.1. Introduction

7.2. Top winning strategies

7.3. Product Mapping of Top 10 Player

7.4. Competitive Dashboard

7.5. Competitive Heatmap

7.6. Top player positioning, 2021

CHAPTER 8: COMPANY PROFILES

8.1 Thermo Fisher Scientific Inc.

8.1.1 Company overview

8.1.2 Key Executives

8.1.3 Company snapshot

8.1.4 Operating business segments

8.1.5 Product portfolio

8.1.6 Business performance

8.1.7 Key strategic moves and developments

8.2 Merck KGaA

8.2.1 Company overview

8.2.2 Key Executives

8.2.3 Company snapshot

8.2.4 Operating business segments

8.2.5 Product portfolio

8.2.6 Business performance

8.2.7 Key strategic moves and developments

8.3 Waters Corporation

8.3.1 Company overview

8.3.2 Key Executives

8.3.3 Company snapshot

8.3.4 Operating business segments

8.3.5 Product portfolio

8.3.6 Business performance

8.3.7 Key strategic moves and developments

8.4 Bio-Rad Laboratories Inc

8.4.1 Company overview

8.4.2 Key Executives

8.4.3 Company snapshot

8.4.4 Operating business segments

8.4.5 Product portfolio

8.4.6 Business performance

8.4.7 Key strategic moves and developments

8.5 Agilent Technologies Inc.

8.5.1 Company overview

8.5.2 Key Executives

8.5.3 Company snapshot

8.5.4 Operating business segments

8.5.5 Product portfolio

8.5.6 Business performance

8.5.7 Key strategic moves and developments

8.6 Li-Cor Inc

8.6.1 Company overview

8.6.2 Key Executives

8.6.3 Company snapshot

8.6.4 Operating business segments

8.6.5 Product portfolio

8.6.6 Business performance

8.6.7 Key strategic moves and developments

8.7 Bruker Corporation

8.7.1 Company overview

8.7.2 Key Executives

8.7.3 Company snapshot

8.7.4 Operating business segments

8.7.5 Product portfolio

8.7.6 Business performance

8.7.7 Key strategic moves and developments

8.8 Perkin Elmer Inc

8.8.1 Company overview

8.8.2 Key Executives

8.8.3 Company snapshot

8.8.4 Operating business segments

8.8.5 Product portfolio

8.8.6 Business performance

8.8.7 Key strategic moves and developments

8.9 Danaher Corporation

8.9.1 Company overview

8.9.2 Key Executives

8.9.3 Company snapshot

8.9.4 Operating business segments

8.9.5 Product portfolio

8.9.6 Business performance

8.9.7 Key strategic moves and developments

8.10 Horiba Ltd.

8.10.1 Company overview

8.10.2 Key Executives

8.10.3 Company snapshot

8.10.4 Operating business segments

8.10.5 Product portfolio

8.10.6 Business performance

8.10.7 Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 2. PROTEOMICS MARKET FOR REAGENTS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 3. GLOBAL REAGENTS PROTEOMICS MARKET, BY REAGENTS TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 4. PROTEOMICS MARKET FOR INSTRUMENTS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 5. GLOBAL INSTRUMENTS PROTEOMICS MARKET, BY INSTRUMENTS TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 6. GLOBAL SPECTROMETRY PROTEOMICS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 7. GLOBAL CHROMATOGRAPHY PROTEOMICS MARKET, BY TYPE, 2021-2031 (REVENUE, $MILLION)

TABLE 8. PROTEOMICS MARKET FOR SERVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 9. GLOBAL PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 10. PROTEOMICS MARKET FOR DRUG DISCOVERY, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 11. PROTEOMICS MARKET FOR DISEASE DIAGNOSIS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 12. PROTEOMICS MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 13. PROTEOMICS MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)

TABLE 14. NORTH AMERICA PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 15. NORTH AMERICA PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 16. NORTH AMERICA PROTEOMICS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 17. U.S. PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 18. U.S. PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 19. CANADA PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 20. CANADA PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 21. MEXICO PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 22. MEXICO PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 23. EUROPE PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 24. EUROPE PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 25. EUROPE PROTEOMICS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 26. GERMANY PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 27. GERMANY PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 28. FRANCE PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 29. FRANCE PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 30. UK PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 31. UK PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 32. ITALY PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 33. ITALY PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 34. SPAIN PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 35. SPAIN PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 36. REST OF EUROPE PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 37. REST OF EUROPE PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 38. ASIA-PACIFIC PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 39. ASIA-PACIFIC PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 40. ASIA-PACIFIC PROTEOMICS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 41. JAPAN PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 42. JAPAN PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 43. CHINA PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 44. CHINA PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 45. AUSTRALIA PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 46. AUSTRALIA PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 47. INDIA PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 48. INDIA PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 49. SOUTH KOREA PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 50. SOUTH KOREA PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 51. REST OF ASIA-PACIFIC PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 52. REST OF ASIA-PACIFIC PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 53. LAMEA PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 54. LAMEA PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 55. LAMEA PROTEOMICS MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)

TABLE 56. BRAZIL PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 57. BRAZIL PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 58. SAUDI ARABIA PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 59. SAUDI ARABIA PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 60. SOUTH AFRICA PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 61. SOUTH AFRICA PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 62. REST OF LAMEA PROTEOMICS MARKET, BY COMPONENT, 2021-2031 (REVENUE, $MILLION)

TABLE 63. REST OF LAMEA PROTEOMICS MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)

TABLE 65.THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES

TABLE 65.THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT

TABLE 66.THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS

TABLE 67.THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO

TABLE 68.THERMO FISHER SCIENTIFIC INC.: NET SALES

TABLE 69.THERMO FISHER SCIENTIFIC INC.: KEY STRATERGIES

TABLE 71.BIO-RAD LABORATORIES INC: KEY EXECUTIVES

TABLE 71.BIO-RAD LABORATORIES INC: COMPANY SNAPSHOT

TABLE 72.BIO-RAD LABORATORIES INC: OPERATING SEGMENTS

TABLE 73.BIO-RAD LABORATORIES INC: PRODUCT PORTFOLIO

TABLE 74.BIO-RAD LABORATORIES INC: NET SALES

TABLE 75.BIO-RAD LABORATORIES INC: KEY STRATERGIES

TABLE 77.AGILENT TECHNOLOGIES INC.: KEY EXECUTIVES

TABLE 77.AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT

TABLE 78.AGILENT TECHNOLOGIES INC.: OPERATING SEGMENTS

TABLE 79.AGILENT TECHNOLOGIES INC.: PRODUCT PORTFOLIO

TABLE 80.AGILENT TECHNOLOGIES INC.: NET SALES

TABLE 81.AGILENT TECHNOLOGIES INC.: KEY STRATERGIES

TABLE 83.MERCK KGAA: KEY EXECUTIVES

TABLE 83.MERCK KGAA: COMPANY SNAPSHOT

TABLE 84.MERCK KGAA: OPERATING SEGMENTS

TABLE 85.MERCK KGAA: PRODUCT PORTFOLIO

TABLE 86.MERCK KGAA: NET SALES

TABLE 87.MERCK KGAA: KEY STRATERGIES

TABLE 89.LI-COR INC: KEY EXECUTIVES

TABLE 89.LI-COR INC: COMPANY SNAPSHOT

TABLE 90.LI-COR INC: OPERATING SEGMENTS

TABLE 91.LI-COR INC: PRODUCT PORTFOLIO

TABLE 92.LI-COR INC: NET SALES

TABLE 93.LI-COR INC: KEY STRATERGIES

TABLE 95.WATERS CORPORATION: KEY EXECUTIVES

TABLE 95.WATERS CORPORATION: COMPANY SNAPSHOT

TABLE 96.WATERS CORPORATION: OPERATING SEGMENTS

TABLE 97.WATERS CORPORATION: PRODUCT PORTFOLIO

TABLE 98.WATERS CORPORATION: NET SALES

TABLE 99.WATERS CORPORATION: KEY STRATERGIES

TABLE 101.BRUKER CORPORATION: KEY EXECUTIVES

TABLE 101.BRUKER CORPORATION: COMPANY SNAPSHOT

TABLE 102.BRUKER CORPORATION: OPERATING SEGMENTS

TABLE 103.BRUKER CORPORATION: PRODUCT PORTFOLIO

TABLE 104.BRUKER CORPORATION: NET SALES

TABLE 105.BRUKER CORPORATION: KEY STRATERGIES

TABLE 107.PERKIN ELMER INC: KEY EXECUTIVES

TABLE 107.PERKIN ELMER INC: COMPANY SNAPSHOT

TABLE 108.PERKIN ELMER INC: OPERATING SEGMENTS

TABLE 109.PERKIN ELMER INC: PRODUCT PORTFOLIO

TABLE 110.PERKIN ELMER INC: NET SALES

TABLE 111.PERKIN ELMER INC: KEY STRATERGIES

TABLE 113.DANAHER CORPORATION: KEY EXECUTIVES

TABLE 113.DANAHER CORPORATION: COMPANY SNAPSHOT

TABLE 114.DANAHER CORPORATION: OPERATING SEGMENTS

TABLE 115.DANAHER CORPORATION: PRODUCT PORTFOLIO

TABLE 116.DANAHER CORPORATION: NET SALES

TABLE 117.DANAHER CORPORATION: KEY STRATERGIES

TABLE 119.HORIBA LTD.: KEY EXECUTIVES

TABLE 119.HORIBA LTD.: COMPANY SNAPSHOT

TABLE 120.HORIBA LTD.: OPERATING SEGMENTS

TABLE 121.HORIBA LTD.: PRODUCT PORTFOLIO

TABLE 122.HORIBA LTD.: NET SALES

TABLE 123.HORIBA LTD.: KEY STRATERGIES

LIST OF FIGURES

FIGURE 1. SEGMENTATION OF PROTEOMICS MARKET,2021-2031

FIGURE 2.PROTEOMICS MARKET,2021-2031

FIGURE 3. TOP INVESTMENT POCKETS, BY REGION

FIGURE 4.PORTER FIVE-1

FIGURE 5.PORTER FIVE-2

FIGURE 6.PORTER FIVE-3

FIGURE 7.PORTER FIVE-4

FIGURE 8.PORTER FIVE-5

FIGURE 9.PROTEOMICS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES

FIGURE 10.PROTEOMICS MARKET,BY COMPONENT,2021(%)

FIGURE 11.COMPARATIVE SHARE ANALYSIS OF REAGENTS PROTEOMICS MARKET, 2021 AND 2031(%)

FIGURE 12.COMPARATIVE SHARE ANALYSIS OF INSTRUMENTS PROTEOMICS MARKET, 2021 AND 2031(%)

FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SERVICES PROTEOMICS MARKET, 2021 AND 2031(%)

FIGURE 14.PROTEOMICS MARKET,BY APPLICATION,2021(%)

FIGURE 15.COMPARATIVE SHARE ANALYSIS OF DRUG DISCOVERY PROTEOMICS MARKET, 2021 AND 2031(%)

FIGURE 16.COMPARATIVE SHARE ANALYSIS OF DISEASE DIAGNOSIS PROTEOMICS MARKET, 2021 AND 2031(%)

FIGURE 17.COMPARATIVE SHARE ANALYSIS OF OTHERS PROTEOMICS MARKET, 2021 AND 2031(%)

FIGURE 18.PROTEOMICS MARKET BY REGION,2021

FIGURE 19.U.S. PROTEOMICS MARKET,2021-2031($MILLION)

FIGURE 20.CANADA PROTEOMICS MARKET,2021-2031($MILLION)

FIGURE 21.MEXICO PROTEOMICS MARKET,2021-2031($MILLION)

FIGURE 22.GERMANY PROTEOMICS MARKET,2021-2031($MILLION)

FIGURE 23.FRANCE PROTEOMICS MARKET,2021-2031($MILLION)

FIGURE 24.UK PROTEOMICS MARKET,2021-2031($MILLION)

FIGURE 25.ITALY PROTEOMICS MARKET,2021-2031($MILLION)

FIGURE 26.SPAIN PROTEOMICS MARKET,2021-2031($MILLION)

FIGURE 27.REST OF EUROPE PROTEOMICS MARKET,2021-2031($MILLION)

FIGURE 28.JAPAN PROTEOMICS MARKET,2021-2031($MILLION)

FIGURE 29.CHINA PROTEOMICS MARKET,2021-2031($MILLION)

FIGURE 30.AUSTRALIA PROTEOMICS MARKET,2021-2031($MILLION)

FIGURE 31.INDIA PROTEOMICS MARKET,2021-2031($MILLION)

FIGURE 32.SOUTH KOREA PROTEOMICS MARKET,2021-2031($MILLION)

FIGURE 33.REST OF ASIA-PACIFIC PROTEOMICS MARKET,2021-2031($MILLION)

FIGURE 34.BRAZIL PROTEOMICS MARKET,2021-2031($MILLION)

FIGURE 35.SAUDI ARABIA PROTEOMICS MARKET,2021-2031($MILLION)

FIGURE 36.SOUTH AFRICA PROTEOMICS MARKET,2021-2031($MILLION)

FIGURE 37.REST OF LAMEA PROTEOMICS MARKET,2021-2031($MILLION)

FIGURE 38. TOP WINNING STRATEGIES, BY YEAR

FIGURE 39. TOP WINNING STRATEGIES, BY DEVELOPMENT

FIGURE 40. TOP WINNING STRATEGIES, BY COMPANY

FIGURE 41.PRODUCT MAPPING OF TOP 10 PLAYERS

FIGURE 42.TOP PLAYER POSITIONING, 2021

FIGURE 43.COMPETITIVE DASHBOARD

FIGURE 44.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS

FIGURE 45.THERMO FISHER SCIENTIFIC INC..: NET SALES ($MILLION)

FIGURE 46.BIO-RAD LABORATORIES INC.: NET SALES ($MILLION)

FIGURE 47.AGILENT TECHNOLOGIES INC..: NET SALES ($MILLION)

FIGURE 48.MERCK KGAA.: NET SALES ($MILLION)

FIGURE 49.LI-COR INC.: NET SALES ($MILLION)

FIGURE 50.WATERS CORPORATION.: NET SALES ($MILLION)

FIGURE 51.BRUKER CORPORATION.: NET SALES ($MILLION)

FIGURE 52.PERKIN ELMER INC.: NET SALES ($MILLION)

FIGURE 53.DANAHER CORPORATION.: NET SALES ($MILLION)

FIGURE 54.HORIBA LTD..: NET SALES ($MILLION)

SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5730

This license allows only one user to access the PDF.
Electronic (PDF)

$6454

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9600

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Electronic (PDF)

$3840

This license just provides quantitative data in a excel sheet
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India